Table 1.
Clinical and plasma biochemical parameters of the abdominal aortic aneurysm (AAA) patients and controls.
| Parameters | Large Size (n = 38) |
Small/Medium Size (n = 81) |
Control (n = 39) |
ANOVA or Chi-Square p-Value |
|---|---|---|---|---|
| Age (y) | 69.71 ± 2.88 | 69.65 ± 2.81 | 68.87 ± 2.69 | ns |
| BMI (%) | 28.03 ± 2.42 † | 27.41 ± 3.48 † | 25.80 ± 2.55 | <0.01 |
| Total cholesterol (mmol/L) | 4.52 ± 0.71 † | 4.87 ± 0.88 | 5.24 ± 0.77 | <0.001 |
| TG (mmol/L) | 0.98 ± 0.40 # | 1.44 ± 0.66 † | 1.10 ± 0.36 | <0.001 |
| ApoA-I (g/L) | 1.53 ± 0.28 † | 1.59 ± 0.32 † | 1.80 ± 0.32 | <0.001 |
| HDLc (mmol/L) | 1.09 ± 0.43 | 1.09 ± 0.40 | 1.22 ± 0.42 | ns |
| LDLc (mmol/L) | 2.98 ± 0.81 † | 3.13 ± 0.90 | 3.52 ± 0.89 | <0.05 |
| VLDLc (mmol/L) | 0.45 ± 0.19 # | 0.65 ± 0.26 † | 0.50 ± 0.16 | <0.001 |
| Aortic diameter (mm) | 62.52 ± 15.35 †,# | 36.35 ± 4.54 † | 18.16 ± 2.90 | <0.001 |
| DBP (mm Hg) | 91.00 ± 13.62 † | 88.00 ± 12.30 † | 80.97 ± 11.36 | <0.01 |
| Lowest ABI | 0.99 ± 0.11 † | 0.95 ± 0.19 † | 1.10 ± 0.09 | <0.001 |
| Smoking | 8 (2%) | 32 (41%) | 15 (40%) | ns |
| Diabetes | 3 (8%) | 10 (13%) | 4 (8%) | ns |
| Arterial hypertension | 15 (40%) | 41 (52%) | 23 (61%) | ns |
| Previous CVD | 1 (18%) | 11 (14%) | 7 (3%) | ns |
| Statin use | 16 (42%) | 41 (52%) | 20 (53%) | ns |
| Low-dose aspirin | 8 (50%) | 35 (44%) | 19 (22%) | ns |
BMI = body mass index; TG = triglycerides; ApoA-I = apolipoprotein A–I; HDLc = High-density lipoprotein cholesterol; LDLc = low-density lipoprotein cholesterol; VLDLc = very low-density lipoprotein cholesterol; DBP = diastolic blood pressure; ABI = ankle brachial index; CVD = cardiovascular disease (acute myocardial infarction, angina or stroke); ANOVA = analysis of variance. Results expressed as mean ± standard deviation (SD). † p < 0.05 compared to the control group, # p < 0.05 compared to small/medium size, ns = non-significant.